Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 - not as a booster but part of their initial shots.
from The Washington Times stories: Health https://ift.tt/mGnBiAx
from The Washington Times stories: Health https://ift.tt/mGnBiAx